Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector




















Sort by: Date|Relevance

Evotec, Memphasys, MorphoSys - Growth Industry Health

He who is healthy has many desires, he who is ill only one. Companies around the globe deal with diseases and special features of nature in order to treat or cure them. In addition to the widespread disease of cancer, there are also topics that are less talked about, but are a...

BioNTech, Gilead, Memphasys - modern science and COVID and IVF

People around the world are worried about the extent of the consequences associated with the spread of the corona virus COVID-19, and politicians and the economy are called upon to deal with the situation appropriately so that the loss of life and financial damage to the citiz...

Commerzbank, Royal Dutch Shell, Wirecard - Opportunities and Potentials

Price developments on stock markets around the world have led to enormous losses for investors in recent weeks. Particularly hard hit were investors who worked leveraged with credits and had to sell their positions in connection with falling prices. An escalating situation due...

US Biopharma to Launch Phase 3 Trial in Bacterial Vaginosis

Daré Bioscience's study, its prospects and the indication's U.S. market opportunity are discussed in a ROTH Capital Partners report. In a May 15 research note, ROTH Capital Partners analyst Yasmeen Rahimi reviewed why the outlook is positive for Daré Bioscience In...

Insider Tips From a Capital Markets Guru on Trends

When it comes to capital markets, there are few more experienced to teach the do’s and don’ts of trading than Howard Katz – Managing Director of Mackie Research. In this insightful, intriguing and entertaining interview with Dave Jackson of...

What is the gold outlook for the rest of 2024?

Peaking at more than US$2,400 an ounce in April and currently sitting above the US$2,300 mark, the gold case continues to shine. Will this precious metal continue its rise to glory as we enter the second half of the year? And how does gold stack up against a guaranteed in...

VIDEO: Expert Insights Ep 01 - Brady Fletcher, TSXV - PDAC 2019

This series showcases leaders in the industry giving insights into top stories, market sentiment, and trends. In this episode, Stockhouse catches up with Brady Fletcher, Managing Director of the TSX Venture Exchange , at PDAC 2019.

VIDEO: PDAC Part 1 - Companies to Watch - Ep.3

Legends discuss investment opportunities in the resource space and Companies to Watch from PDAC 2019 - Episode 3 features Brady Fletcher, Managing Partner at the TSX Venture Exchange, Goliath Resources ( TSX:V.GOT , OTCQB: GOTRF) , Granada Gold Mine Inc. ( TS...

PROFIT! A NEW Stockhouse Vodcast Series. Eps. 1

Get to know capital market moguls, mavens and management teams in a more relaxed setting. Episodes open with fun, rapid-fire questions, setting the tone for a more informal one-on-one session. You won’t want to miss our weekly releases featuring thought ...

Breaking Down the Multibillion-Dollar Biologicals Market

(Click to play video) Investors aware of the biologicals market know that it has been quietly building up over the last few years. From mergers and acquisition deals north of a billion dollars to a steady presence in industry and mainstream news, the sector is o...
1 2 3 4 5 6 7 8 9 10 ...